Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
NCT07464132Phase 2Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Dec 2025
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga-DOTA-NI-FAPI04 in tumor, cardiovascular disease (CVD), pulmonary fibrosis (PF), autoimmune rheumatic diseases (ARDs), hypertrophic cardiomyopathy (HCM), sponsored by Peking Union Medical College Hospital. Started Dec 2025; status: recruiting.
02
Drugs
68Ga-DOTA-NI-FAPI04
03
Conditions
tumorcardiovascular disease (CVD)pulmonary fibrosis (PF)autoimmune rheumatic diseases (ARDs)hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT07464132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07464132.